Skip to content
ANAVEX
ANAVEX
  • HOME
  • ABOUT US
  • NEWS
  • PIPELINE
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
  • JOIN US
Search
  • HOME
  • ABOUT US
  • NEWS
  • PIPELINE
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
  • JOIN US

Oxidative Damage Is the Earliest Event in Alzheimer Disease

Alzheimer's DiseaseBy alessandroAugust 10, 2001

Journal of Neuropathology and Experimental Neurology Vol. 60, No. 8, August, 2001 Akihiko Nunomura, MD, PH.D., George Perry, PH.D., Gjumrakch Aliev, MD, PH.D., Keisuke Hirai, PH.D., Atsushi Takeda, MD, PH.D., Elizabeth K. Balraj, MD, Paul K. Jones, PH.D., Hossein Ghanbari, PH.D., Takafumi Wataya, MD, Shun Shimohama, MD, PH.D., Shigeru Chiba, MD, PH.D., Craig S. Atwood,…

Molecular cloning and pharmacological characterization of the rat σ1 receptor.

PIPELINEBy alessandroAugust 1, 2001

Biochem Pharmacol 62, 349-355, (2001). Mei, J., & Pasternak, G. W. View abstract in PubMed

ANAVEX® is a trademark of Anavex®Life Sciences Corp. - 2019 All Rights Reserved

Go to Top